| A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells KE Harris, KJ Lorentsen, HK Malik-Chaudhry, K Loughlin, HM Basappa, ... Scientific Reports 11 (1), 10592, 2021 | 26 | 2021 |
| A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer BC Avanzino, K Prabhakar, P Dalvi, S Hartstein, H Kehm, ... Oncoimmunology 11 (1), 2113697, 2022 | 6 | 2022 |
| Anti-muc1-c antibodies and car-t structures K Harris, B Avanzino, N Trinklein, K Chang, N Allen US Patent App. 18/547,663, 2024 | | 2024 |
| Anti-cd20 antibodies and car-t structures N Trinklein, K Harris, N Allen, K Chang, B Avanzino US Patent App. 18/473,965, 2024 | | 2024 |
| Anti-cd19 antibodies and car-t structures N Trinklein, K Harris, B Avanzino, JS Lucas, L Davison, BB Madison, ... US Patent App. 18/473,057, 2024 | | 2024 |
| AT cell engaging bispecific antibody utilizing a bivalent tumor-selective folate receptor alpha binding arm for the treatment of ovarian cancer BC Avanzino, K Prabhakar, P Dalvi, S Hartstein, H Kehm, ... Cancer Research 82 (12_Supplement), 6244-6244, 2022 | | 2022 |
